Taysha Gene Therapies (TSHA) Cash from Investing Activities (2020 - 2026)
Taysha Gene Therapies (TSHA) reported Cash from Investing Activities of $1,000 for Q2 2026, down 98.4% from $62,000 a year earlier.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Taysha Gene Therapies' Cash from Investing Activities came in at -$3.32 million; for FY2025, it came in at -$604,000.
- By year, Cash from Investing Activities came in at -$363,000 in FY2024, -$7.35 million in FY2023, -$24.93 million in FY2022 and -$21.55 million in FY2021.
- Five-year quarterly Cash from Investing Activities spans a low of -$11.43 million in Q1 2022 and a high of $62,000 in Q2 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$3.02 million (Q1 2026), -$247,000 (Q4 2025) and -$48,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Taysha Gene Therapies | 1.51 Bn | 1.51 Bn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | -3.02 Mn |
| Dec 31, 2025 | -247,000.00 |
| Sep 30, 2025 | -48,000.00 |
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | -371,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -201,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | -3.49 Mn |
| Jun 30, 2023 | 48,000.00 |
| Mar 31, 2023 | -3.90 Mn |
| Dec 31, 2022 | -2.37 Mn |
| Sep 30, 2022 | -3.02 Mn |
| Jun 30, 2022 | -8.11 Mn |
| Mar 31, 2022 | -11.43 Mn |
| Dec 31, 2021 | -8.52 Mn |
| Sep 30, 2021 | -4.00 Mn |
API Access
Taysha Gene Therapies Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();